Stock Research for EVOK

EVOK

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

EVOK Stock Chart & Research Data

The EVOK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EVOK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EVOK Due diligence Resources & Stock Charts

The EVOK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EVOK Detailed Price Forecast - CNN Money CNN View EVOK Detailed Summary - Google Finance
Yahoo View EVOK Detailed Summary - Yahoo! Finance Zacks View EVOK Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View EVOK Trends & Analysis - Trade-Ideas Barrons View EVOK Major Holders - Barrons
NASDAQ View EVOK Call Transcripts - NASDAQ Seeking View EVOK Breaking News & Analysis - Seeking Alpha
Spotlight View EVOK Annual Report - CompanySpotlight.com OTC Report View EVOK OTC Short Report - OTCShortReport.com
TradeKing View EVOK Fundamentals - TradeKing Charts View EVOK SEC Filings - Bar Chart
WSJ View Historical Prices for EVOK - The WSJ Morningstar View Performance/Total Return for EVOK - Morningstar
MarketWatch View the Analyst Estimates for EVOK - MarketWatch CNBC View the Earnings History for EVOK - CNBC
StockMarketWatch View the EVOK Earnings - StockMarketWatch MacroAxis View EVOK Buy or Sell Recommendations - MacroAxis
Bullish View the EVOK Bullish Patterns - American Bulls Short Pains View EVOK Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View EVOK Stock Mentions - StockTwits PennyStocks View EVOK Stock Mentions - PennyStockTweets
Twitter View EVOK Stock Mentions - Twitter Invest Hub View EVOK Investment Forum News - Investor Hub
Yahoo View EVOK Stock Mentions - Yahoo! Message Board Seeking Alpha View EVOK Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for EVOK - SECform4.com Insider Cow View Insider Transactions for EVOK - Insider Cow
CNBC View EVOK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EVOK - OTC Markets
Yahoo View Insider Transactions for EVOK - Yahoo! Finance NASDAQ View Institutional Holdings for EVOK - NASDAQ


Stock Charts

FinViz View EVOK Stock Insight & Charts - FinViz.com StockCharts View EVOK Investment Charts - StockCharts.com
BarChart View EVOK Stock Overview & Charts - BarChart Trading View View EVOK User Generated Charts - Trading View




Latest Financial News for EVOK


Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
Posted on Wednesday April 17, 2024

Michael Cline, DO., Medical Director Gastroparesis Clinic, Cleveland Clinic to presentSOLANA BEACH, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced it will host a virtual KOL and investor webinar on Wednesday, April 24 at 12:00 p.m. ET. Moderated by Yale Jen, PhD, Senior Managing Director of Equity


Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
Posted on Thursday March 21, 2024

SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that Matthew J. D’Onofrio will be succeeding David A. Gonyer as Chief Executive Officer as of March 31, 2024 upon Mr. Gonyer’s departure for personal reasons. Mr. D’Onofrio currently serves as President and Chief Operating Officer. “Worki


Evoke Pharma, Inc. (NASDAQ:EVOK): Are Analysts Optimistic?
Posted on Saturday March 16, 2024

We feel now is a pretty good time to analyse Evoke Pharma, Inc.'s ( NASDAQ:EVOK ) business as it appears the company...


Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript
Posted on Friday March 15, 2024

Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript March 14, 2024 Evoke Pharma, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.5. Evoke Pharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, […]


Stock Market & Investing Books

Enter a stock symbol to view the stock details.